ALMS
Ticker
Alumis Inc.
ALMS · Healthcare · Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disor…Alumis Inc. (ALMS), in the Healthcare sector, has 18 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 17 purchases and 2 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 10. The most active filer was Srinivas Akkaraju with 9 filings.
Add to watchlistFilings, ttm
18
17 buys · 2 sells
Traders, ttm
5
5 insiders
Volume, ttmiDollar value disclosed in the window
$62.8M
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Sep 8
Filed Sep 9
ADViAverage daily dollar volume
$31.6M
market data
Share price · 12M
$7.94 (+91.3%)
Adjusted for splits and dividends.
Volume by month
Buys $63.7M
Sells $1.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
SARecent filings
Srinivas AkkarajuPURCHASE
Director
$10.7M986,721 sh across 4 lots
Exec Sep 4
Filed Sep 9 · 9:39 PM ET Srinivas AkkarajuSALE Director $1.0M
96,131 sh across 2 lots
Exec Sep 8
Filed Sep 9 · 9:39 PM ET Sanam PangaliSALE Chief Legal Officer $140K
5,000 sh × $28.00
Exec Jul 6
Filed Jul 8 · 4:40 PM ET Srinivas AkkarajuPURCHASE Director $10.0M
588,235 sh × $17.00
Exec Jan 9
Filed Jan 13 · 6:20 PM ET Foresite Labs, LLCPURCHASE 10% owner $7.0M
411,764 sh across 2 lots
Exec Jan 8
Filed Jan 12 · 9:59 PM ET Foresite Capital Management VI LLCPURCHASE 10% owner $7.0M
411,764 sh across 2 lots
Exec Jan 8
Filed Jan 12 · 9:58 PM ET James B. TananbaumPURCHASE Director $7.0M
411,764 sh across 2 lots
Exec Jan 8
Filed Jan 12 · 9:58 PM ET Srinivas AkkarajuPURCHASE Director $1.8M
186,377 sh across 3 lots
Exec Dec 5 2025
Filed Dec 9 2025 · 7:13 PM ET Srinivas AkkarajuPURCHASE Director $2.0M
262,027 sh across 3 lots
Exec Dec 2 2025
Filed Dec 4 2025 · 8:11 PM ET Srinivas AkkarajuPURCHASE Director $1.3M
173,589 sh across 3 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 6:09 PM ET Foresite Capital Management VI LLCPURCHASE 10% owner $533K
72,212 sh × $7.38
Exec Nov 21 2025
Filed Nov 25 2025 · 4:02 PM ET James B. TananbaumPURCHASE Director $533K
72,212 sh × $7.38
Exec Nov 21 2025
Filed Nov 25 2025 · 4:02 PM ET Foresite Labs, LLCPURCHASE 10% owner $533K
72,212 sh × $7.38
Exec Nov 21 2025
Filed Nov 25 2025 · 4:01 PM ET Srinivas AkkarajuPURCHASE Director $905K
125,743 sh × $7.20
Exec Nov 20 2025
Filed Nov 24 2025 · 6:50 PM ET Foresite Labs, LLCPURCHASE 10% owner $3.1M
507,874 sh across 4 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 8:54 PM ET Foresite Capital Management VI LLCPURCHASE 10% owner $3.1M
507,874 sh across 4 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 8:52 PM ET James B. TananbaumPURCHASE Director $3.1M
507,874 sh across 4 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 8:51 PM ET Srinivas AkkarajuPURCHASE Director $1.5M
240,424 sh across 2 lots
Exec Nov 18 2025
Filed Nov 19 2025 · 8:46 PM ET Srinivas AkkarajuPURCHASE Director $1.4M
276,179 sh × $5.25
Exec Nov 13 2025
Filed Nov 17 2025 · 4:59 PM ET Srinivas AkkarajuPURCHASE Director $1.5M
320,290 sh across 3 lots
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET Foresite Labs Management I, LLCPURCHASE 10% owner $116K
25,000 sh × $4.62
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET Foresite Labs Affiliates 2021, LLCPURCHASE 10% owner $116K
25,000 sh × $4.62
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET James B. TananbaumPURCHASE Director $116K
25,000 sh × $4.62
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET Martin BablerPURCHASE President, CEO and Chairman $101K
15,650 sh × $6.44
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET Alan ColowickPURCHASE Director $112K
16,104 sh × $6.97
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET